IBDEI0S1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12893,0)
 ;;=67028^^79^750^6^^^^1
 ;;^UTILITY(U,$J,358.3,12893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12893,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,12893,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,12894,0)
 ;;=67500^^79^750^10^^^^1
 ;;^UTILITY(U,$J,358.3,12894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12894,1,2,0)
 ;;=2^Retrobulbar Inj,Medication
 ;;^UTILITY(U,$J,358.3,12894,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,12895,0)
 ;;=67505^^79^750^9^^^^1
 ;;^UTILITY(U,$J,358.3,12895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12895,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,12895,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,12896,0)
 ;;=68200^^79^750^13^^^^1
 ;;^UTILITY(U,$J,358.3,12896,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12896,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,12896,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,12897,0)
 ;;=96372^^79^750^11^^^^1
 ;;^UTILITY(U,$J,358.3,12897,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12897,1,2,0)
 ;;=2^SC/IM Injection
 ;;^UTILITY(U,$J,358.3,12897,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,12898,0)
 ;;=96402^^79^750^12^^^^1
 ;;^UTILITY(U,$J,358.3,12898,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12898,1,2,0)
 ;;=2^SQ/IM Anti-Neplastic Hormone Inj
 ;;^UTILITY(U,$J,358.3,12898,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,12899,0)
 ;;=C9257^^79^750^2^^^^1
 ;;^UTILITY(U,$J,358.3,12899,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12899,1,2,0)
 ;;=2^Bevacizumab Inj 0.25mg
 ;;^UTILITY(U,$J,358.3,12899,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,12900,0)
 ;;=J1094^^79^750^4^^^^1
 ;;^UTILITY(U,$J,358.3,12900,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12900,1,2,0)
 ;;=2^Dexamethasone Acetate Inj per 1mg
 ;;^UTILITY(U,$J,358.3,12900,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,12901,0)
 ;;=J2778^^79^750^8^^^^1
 ;;^UTILITY(U,$J,358.3,12901,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12901,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,12901,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,12902,0)
 ;;=J3300^^79^750^14^^^^1
 ;;^UTILITY(U,$J,358.3,12902,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12902,1,2,0)
 ;;=2^Triescence Inj per 1mg
 ;;^UTILITY(U,$J,358.3,12902,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,12903,0)
 ;;=J3301^^79^750^7^^^^1
 ;;^UTILITY(U,$J,358.3,12903,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12903,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,12903,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,12904,0)
 ;;=J3396^^79^750^15^^^^1
 ;;^UTILITY(U,$J,358.3,12904,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12904,1,2,0)
 ;;=2^Verteporfin Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,12904,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,12905,0)
 ;;=J9035^^79^750^3^^^^1
 ;;^UTILITY(U,$J,358.3,12905,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12905,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,12905,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,12906,0)
 ;;=J0178^^79^750^1^^^^1
 ;;^UTILITY(U,$J,358.3,12906,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12906,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,12906,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,12907,0)
 ;;=67028^^79^751^4^^^^1
 ;;^UTILITY(U,$J,358.3,12907,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12907,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,12907,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,12908,0)
 ;;=J9035^^79^751^3^^^^1
 ;;^UTILITY(U,$J,358.3,12908,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12908,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,12908,1,3,0)
 ;;=3^J9035
